News|Articles|September 2, 2003
- Pharmaceutical Technology-09-02-2003
- Volume 27
- Issue 9
The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride
Author(s)Kilambi Pundarikakshudu, PhD
The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.
Advertisement
Articles in this issue
almost 23 years ago
September 2003almost 23 years ago
In the Spotlight September 2003almost 23 years ago
Counterfeiting, Compliance, and Controlsalmost 23 years ago
September 2003almost 23 years ago
Disposable Filtration Lightens Cleaning and Validation Loadalmost 23 years ago
CROs Hoping for Research Burst in Second Half of 2003almost 23 years ago
Improved Blister Packaging Benefits Consumers, Caregivers, and Drug MakersAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Documentation Reliability Across Contractors: A Quality Systems Approach
3
What to Know About Regulations in June 2026
4
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
5